• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Toll样受体与动脉粥样硬化:疾病与健康的关键因素?

Toll-like receptors and atherosclerosis: key contributors in disease and health?

作者信息

Mullick Adam E, Tobias Peter S, Curtiss Linda K

机构信息

Department of Immunology, The Scripps Research Institute, La Jolla, CA, 92037, USA.

出版信息

Immunol Res. 2006;34(3):193-209. doi: 10.1385/IR:34:3:193.

DOI:10.1385/IR:34:3:193
PMID:16891671
Abstract

The identification of Toll-like receptors (TLRs) as key patternrecognition receptors of innate immunity has opened inquiries into previously unknown disease mechanisms. The ability of TLRs to detect a spectrum of pathogen-derived molecules defines their importance in innate immunity and provides a mechanistic link between infection and disease. Atherosclerosis is a chronic inflammatory disease where immune and metabolic factors interact to initiate and propagate arterial lesions. An understanding of TLRs in atherosclerosis could clarify the etiology of this complex process. Furthermore, the existence of host-derived endogenous TLR ligands may implicate TLR involvement in disease mechanisms beyond innate immunity, such as a role in homeostatic mechanisms to resolve injury. Our current knowledge of TLRs in atherosclerosis is discussed in this review with emphasis on experimental studies in atherosclerosis-susceptible mouse models. Highlights from studies of TLR involvement in other disease processes have demonstrated that TLR-dependent mechanisms probably parallel those found in atherosclerosis, some of which could be important in mitigating atherosclerotic injury. Finally, an appreciation of the pro- and anti-atherosclerotic mechanisms of TLR activation over the entire lifetime of an organism will provide clues to the role of TLRs in both health and disease.

摘要

Toll样受体(TLRs)作为固有免疫的关键模式识别受体,开启了对以前未知疾病机制的探究。TLRs检测一系列病原体衍生分子的能力,决定了它们在固有免疫中的重要性,并在感染与疾病之间提供了一种机制联系。动脉粥样硬化是一种慢性炎症性疾病,免疫和代谢因素相互作用以启动和传播动脉病变。了解动脉粥样硬化中的TLRs有助于阐明这一复杂过程的病因。此外,宿主来源的内源性TLR配体的存在,可能意味着TLRs参与了固有免疫之外的疾病机制,比如在解决损伤的稳态机制中发挥作用。本综述讨论了我们目前对动脉粥样硬化中TLRs的认识,重点是对动脉粥样硬化易感小鼠模型的实验研究。TLRs参与其他疾病过程的研究亮点表明,TLR依赖的机制可能与动脉粥样硬化中的机制相似,其中一些机制可能对减轻动脉粥样硬化损伤很重要。最后,了解生物体整个生命周期中TLR激活的促动脉粥样硬化和抗动脉粥样硬化机制,将为TLRs在健康和疾病中的作用提供线索。

相似文献

1
Toll-like receptors and atherosclerosis: key contributors in disease and health?Toll样受体与动脉粥样硬化:疾病与健康的关键因素?
Immunol Res. 2006;34(3):193-209. doi: 10.1385/IR:34:3:193.
2
Toll-like receptors, their ligands, and atherosclerosis.Toll样受体、其配体与动脉粥样硬化。
ScientificWorldJournal. 2011 Feb 14;11:437-53. doi: 10.1100/tsw.2011.36.
3
Innate immunity, Toll-like receptors, and atherosclerosis: mouse models and methods.天然免疫、Toll样受体与动脉粥样硬化:小鼠模型与方法
Methods Mol Biol. 2009;517:381-99. doi: 10.1007/978-1-59745-541-1_23.
4
Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets.治疗动脉粥样硬化:Toll样受体作为治疗靶点的潜力
Expert Rev Cardiovasc Ther. 2010 Nov;8(11):1619-35. doi: 10.1586/erc.10.149.
5
The toll of Toll-like receptors, especially toll-like receptor 2, on murine atherosclerosis.Toll样受体,尤其是Toll样受体2,对小鼠动脉粥样硬化的影响。
Curr Drug Targets. 2007 Dec;8(12):1230-8. doi: 10.2174/138945007783220605.
6
Endogenous inflammatory molecules engage Toll-like receptors in cardiovascular disease.内源性炎症分子在心血管疾病中通过 Toll 样受体发挥作用。
J Innate Immun. 2010;2(4):307-15. doi: 10.1159/000314270. Epub 2010 Apr 30.
7
The roles of Toll-like receptors in atherosclerosis.Toll 样受体在动脉粥样硬化中的作用。
J Innate Immun. 2009;1(4):340-9. doi: 10.1159/000191413. Epub 2009 Jan 8.
8
Activation of the innate immune system in atherosclerotic disease.动脉粥样硬化疾病中固有免疫系统的激活。
Curr Pharm Des. 2007;13(10):983-94. doi: 10.2174/138161207780487593.
9
Essential Roles of Toll-Like Receptors in Atherosclerosis.Toll样受体在动脉粥样硬化中的重要作用。
Curr Med Chem. 2016;23(5):431-54. doi: 10.2174/0929867323666151207111408.
10
Modulation of toll-like receptors by insulin.胰岛素对 Toll 样受体的调节作用。
Am J Ther. 2011 Sep;18(5):e130-7. doi: 10.1097/MJT.0b013e3181e71fa0.

引用本文的文献

1
Association between the expression of TLR4, TLR2, and MyD88 with low-grade chronic inflammation in individuals with metabolically healthy obesity.代谢健康型肥胖个体中TLR4、TLR2和MyD88的表达与低度慢性炎症之间的关联
Mol Biol Rep. 2023 May;50(5):4723-4728. doi: 10.1007/s11033-023-08338-z. Epub 2023 Mar 11.
2
Immune-Mediated Inflammation in Vulnerable Atherosclerotic Plaques.易损粥样硬化斑块中的免疫介导炎症
Molecules. 2019 Aug 23;24(17):3072. doi: 10.3390/molecules24173072.
3
Mechanisms of erosion of atherosclerotic plaques.

本文引用的文献

1
Toll-like receptors and atherosclerosis: oxidized LDL as an endogenous Toll-like receptor ligand.Toll样受体与动脉粥样硬化:氧化型低密度脂蛋白作为内源性Toll样受体配体
Future Cardiol. 2005 Nov;1(6):785-92. doi: 10.2217/14796678.1.6.785.
2
Inflammation and atherosclerosis.炎症与动脉粥样硬化。
Annu Rev Pathol. 2006;1:297-329. doi: 10.1146/annurev.pathol.1.110304.100100.
3
Regulation of lung injury and repair by Toll-like receptors and hyaluronan.Toll样受体与透明质酸对肺损伤及修复的调控
动脉粥样硬化斑块侵蚀的机制。
Curr Opin Lipidol. 2017 Oct;28(5):434-441. doi: 10.1097/MOL.0000000000000440.
4
Cathepsin L promotes Vascular Intimal Hyperplasia after Arterial Injury.组织蛋白酶 L 促进动脉损伤后的血管内膜增生。
Mol Med. 2017 Jun;23:92-100. doi: 10.2119/molmed.2016.00222. Epub 2016 Mar 20.
5
Upregulation of inflammatory gene transcripts in periosteum of chronic migraineurs: Implications for extracranial origin of headache.慢性偏头痛患者骨膜中炎症基因转录本的上调:对头痛颅外起源的影响。
Ann Neurol. 2016 Jun;79(6):1000-13. doi: 10.1002/ana.24665. Epub 2016 May 5.
6
Impact of Systemic Inflammation on the Progression of Gestational Diabetes Mellitus.全身炎症对妊娠期糖尿病进展的影响。
Curr Diab Rep. 2016 Apr;16(4):26. doi: 10.1007/s11892-016-0715-9.
7
miR-223 Inhibits Lipid Deposition and Inflammation by Suppressing Toll-Like Receptor 4 Signaling in Macrophages.微小RNA-223通过抑制巨噬细胞中Toll样受体4信号传导来抑制脂质沉积和炎症。
Int J Mol Sci. 2015 Oct 20;16(10):24965-82. doi: 10.3390/ijms161024965.
8
Expression of toll-like receptor 4 in maternal monocytes of patients with gestational diabetes mellitus.妊娠糖尿病患者母体单核细胞中Toll样受体4的表达
Exp Ther Med. 2014 Jan;7(1):236-240. doi: 10.3892/etm.2013.1360. Epub 2013 Oct 24.
9
Short-term exercise training improves insulin sensitivity but does not inhibit inflammatory pathways in immune cells from insulin-resistant subjects.短期运动训练可改善胰岛素敏感性,但不能抑制胰岛素抵抗患者免疫细胞中的炎症通路。
J Diabetes Res. 2013;2013:107805. doi: 10.1155/2013/107805. Epub 2013 Mar 13.
10
Novel risk factors for cardiovascular disease in rheumatoid arthritis.类风湿关节炎患者心血管疾病的新危险因素。
Immunol Res. 2013 Jul;56(2-3):267-86. doi: 10.1007/s12026-013-8398-7.
Nat Med. 2005 Nov;11(11):1173-9. doi: 10.1038/nm1315. Epub 2005 Oct 23.
4
Modulation of atherosclerosis in mice by Toll-like receptor 2.Toll样受体2对小鼠动脉粥样硬化的调节作用
J Clin Invest. 2005 Nov;115(11):3149-56. doi: 10.1172/JCI25482. Epub 2005 Oct 6.
5
Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney.肾脏相关的Toll样受体2介导肾脏缺血/再灌注损伤。
J Clin Invest. 2005 Oct;115(10):2894-903. doi: 10.1172/JCI22832.
6
The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages.基质成分双糖链蛋白聚糖具有促炎作用,并通过巨噬细胞中的Toll样受体4和2发出信号。
J Clin Invest. 2005 Aug;115(8):2223-33. doi: 10.1172/JCI23755. Epub 2005 Jul 14.
7
A role for oxidized phospholipids in atherosclerosis.氧化磷脂在动脉粥样硬化中的作用。
N Engl J Med. 2005 Jul 7;353(1):9-11. doi: 10.1056/NEJMp058118.
8
The role of natural antibodies in atherogenesis.天然抗体在动脉粥样硬化形成中的作用。
J Lipid Res. 2005 Jul;46(7):1353-63. doi: 10.1194/jlr.R500005-JLR200. Epub 2005 May 16.
9
A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis.一种常见的Toll样受体(TLR)-2基因多态性是冠状动脉再狭窄的一个危险因素。
J Mol Med (Berl). 2005 Jun;83(6):478-85. doi: 10.1007/s00109-005-0643-7. Epub 2005 May 4.
10
Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development.Toll样受体2刺激可诱导内膜增生和动脉粥样硬化病变发展。
Cardiovasc Res. 2005 Apr 1;66(1):162-9. doi: 10.1016/j.cardiores.2004.12.016. Epub 2005 Jan 13.